For citations:
, , Phosphodiesterase type 5 inhibitor (Levitra): possibility of correction of erectile dysfunction in obese patients. Obesity and metabolism. 2008;5(1):24-29. (In Russ.)
, , Phosphodiesterase type 5 inhibitor (Levitra): possibility of correction of erectile dysfunction in obese patients. Obesity and metabolism. 2008;5(1):24-29. (In Russ.)